Bayo Owens
Psychiatric/Mental Health · Middletown, RINPI 1134884356
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.5% of the total across 191 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 20.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $2,915 and has fallen 60.3% since, to $1,157 in 2025. Among psychiatric/mental health clinicians in RI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 191 payments — averaging $28.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Johnson & Johnson$716
- Teva Pharmaceuticals USA, Inc.$670
- Neurocrine Biosciences, Inc.$587
- Otsuka America Pharmaceutical, Inc.$421
- Alkermes, Inc.$408
- plus $2K from 11 others
What the payments were for
- Food & beverage$5,17895%
- Education$2455%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 44 | $1,105 |
| Johnson & Johnson | 26 | $716 |
| Teva Pharmaceuticals USA, Inc. | 17 | $670 |
| Neurocrine Biosciences, Inc. | 13 | $587 |
| Otsuka America Pharmaceutical, Inc. | 11 | $421 |
| Alkermes, Inc. | 13 | $408 |
| Lundbeck LLC | 14 | $287 |
| Corium, LLC | 11 | $275 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $228 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $198 |
| Ironshore Pharmaceuticals Inc. | 7 | $132 |
| Supernus Pharmaceuticals, Inc. | 5 | $115 |
| Vanda Pharmaceuticals Inc. | 6 | $107 |
| Axsome Therapeutics, Inc. | 4 | $86 |
| Sunovion Pharmaceuticals Inc. | 3 | $50 |
| Indivior Inc. | 1 | $23 |
| Tempus AI, Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,423 in reported general payments places this provider in the 90th percentile of 196 psychiatric/mental health providers in Rhode Island.
See all psychiatric/mental health providers in Rhode Island →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| HetliozTasimelteon | 11 | $234,623 |
| IngrezzaValbenazine Tosylate | 14 | $115,512 |
| AuvelityDextromethorphan Hbr/Bupropion | 12 | $7,973 |
| Aripiprazole | 32 | $2,143 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 24 | $1,528 |
| Buspirone Hcl | 97 | $1,336 |
| Olanzapine | 28 | $1,166 |
| Hydroxyzine Hcl | 95 | $1,068 |
| Atomoxetine Hcl | 17 | $767 |
| Mirtazapine | 38 | $714 |
| Quetiapine Fumarate | 71 | $624 |
| Sertraline Hcl | 28 | $351 |
| Donepezil Hcl | 16 | $253 |
| Benztropine Mesylate | 32 | $211 |
| Divalproex Sodium | 13 | $202 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Vanda Pharmaceuticals Inc.Hetlioz | $107 | $234,62311 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $587 | $115,51214 claims |
| Axsome Therapeutics, Inc.Auvelity | $86 | $7,97312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 196 psychiatric/mental health providers in Rhode Island.
Other psychiatric/mental health in Middletown
- Samantha Shawn MarshBradford$639K
- Samuel KaufmanRiverside$19K
- Katie ThayerWarwick$16K
- Arielle RoundsWarwick$15K
- Eniayo EgberongbeCranston$12K
- Deborah HorvitzWarwick$10K
- Donna McDonaldProvidence$9K
- Timothy PepinNorth Smithfield$9K
- Anita ObengCranston$8K
- Alyssa KortschinskyWarwick$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.